88 results
8-K
EX-1.1
NAVB
Navidea Biopharmaceuticals, Inc.
17 Jun 19
Navidea Biopharmaceuticals Announces Proposed Public Offering of Common Stock
10:00am
, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, post sale warning, “dear
424B5
4zyc4nm 74s
24 Sep 13
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
f6n3c
12 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
sktwvuu
22 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.1
pm5g1ewqdfmfd bkgxd
28 Jun 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
9y2k2xmgrlc7yw8kb
16 May 13
Entry into a Material Definitive Agreement
12:00am
424B5
a6dhvwba5srjh51 0f
24 Apr 13
Prospectus supplement for primary offering
12:00am
424B5
3wjxyz
31 Jan 13
Prospectus supplement for primary offering
12:00am
424B3
4vhdy7m 51ylv
31 Dec 12
Prospectus supplement
12:00am
8-K/A
EX-10.1
u5e6fpiphj6x 8ktjqp
11 Apr 12
Entry into a Material Definitive Agreement
12:00am